Sofinnova Crossover I cuts Abivax voting rights stake below 5% to 4.92% - ABVX News | RalliesSofinnova Crossover I cuts Abivax voting rights stake below 5% to 4.92%
A
ABVX• Sofinnova Crossover I reduces Abivax voting rights stake
- Sofinnova Partners, managing Sofinnova Crossover I, cut its Abivax voting rights stake below 5% on July 1, 2026.
- The fund held 2,877,494 shares, equal to 3.61% of capital, representing 4,042,233 voting rights, or 4.92%.
- The drop followed a rise in total shares and voting rights, combined with market sales.
•
